Regarding your citation to the China trial, you can actually follow the link and read the primary source instead of the Wikipedia summary. https://www.ncbi.nlm.

Regarding your citation to the China trial, you can actually follow the link and read the primary source instead of the Wikipedia summary. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190303/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190303/ The interpretation section states “In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically significant clinical benefits. However, the numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies.” Later on it states “ No patients were enrolled after March 12, because of the control of the outbreak in Wuhan and on the basis of the termination criteria specified in the protocol, the data safety and monitoring board recommended that the study be terminated and data analysed on March 29.“ So that study which you are touting as proving remdesivir didn’t work was stated by its own authors to require a larger study. (China was so successful at suppressing the coronavirus using quarantine and isolation that they ran out of people to test on pretty early on during COVID as well, resulting in a low sample size for studies)